At PACi Therapeutics, we are pioneering novel therapeutic modalities that challenge conventional approaches to drug development. Our platform leverages cutting-edge scientific advances to unlock previously inaccessible biological targets and pathways, creating opportunities for meaningful therapeutic intervention where others have fallen short. Founded by industry veterans with proven track records of clinical and commercial success, we are committed to translating breakthrough science into medicines that fundamentally change patient outcomes.
We welcome conversations with aligned partners and investors
info@pacitherapeutics.comWe envision a future where therapeutic limitations are overcome through innovative molecular design and precision delivery systems. Our commitment extends beyond incremental improvements to creating transformative solutions that redefine treatment paradigms for patients with the highest unmet medical needs.
Built on a foundation of rigorous science and strategic innovation, we combine deep domain expertise with advanced computational approaches to identify and validate novel therapeutic opportunities. Our multidisciplinary team brings together world-class capabilities in molecular engineering, systems biology, and translational medicine.
We collaborate with leading academic institutions, research organizations, and industry partners to accelerate the translation of breakthrough discoveries into clinical reality. Our network includes renowned experts in therapeutic development, regulatory strategy, and commercialization.
Our leadership brings decades of collective experience from premier biotechnology and pharmaceutical companies, with proven success in discovering, developing, and commercializing innovative therapeutics. This expertise spans the entire value chain from early discovery through regulatory approval and market launch.
Dual-Component Therapeutic Platform
Our proprietary platform combines two revolutionary therapeutic modalities that work synergistically to achieve unprecedented precision and efficacy. This innovative dual-component approach enables us to address complex biological challenges through complementary mechanisms of action, creating therapeutic opportunities where traditional approaches have failed.
Precision Biological Engagement
Programmable Therapeutic Effector
The convergence of our peptide architecture and small molecule components creates a therapeutic platform with unparalleled versatility. By leveraging the complementary strengths of each modality - the exquisite selectivity of engineered peptides and the robust cellular penetration of optimized small molecules - we achieve multi-dimensional therapeutic effects. This integrated approach enables precise spatial and temporal control of drug action, opening new therapeutic windows in diseases where monotherapy approaches have proven insufficient.
We welcome opportunities to connect with visionary investors, strategic partners, and exceptional talent who share our commitment to advancing the frontiers of medicine.